Langerin is a natural barrier to HIV-1 transmission by Langerhans cells

Nature Medicine

Volumn 13, Issue 3, 2007, Pages 367-371

  De Witte, Lot ^a   Nabatov, Alexey ^a   Pion, Marjorie ^b   Fluitsma, Donna ^a   De Jong, Marein A W P ^a   De Gruijl, Tanja ^a   Piguet, Vincent ^b   Van Kooyk, Yvette ^a   Geijtenbeek, Teunis B H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; LANGERIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE; VIRUS LOAD; VIRUS TRANSMISSION;

ANIMALS; ANTI-HIV AGENTS; ANTIGENS, CD; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; HIV-1; HUMANS; LANGERHANS CELLS; LECTINS, C-TYPE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED BALB C; PROTEIN BINDING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33847755116     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1541     Document Type: Article

References (25)

1. Lederman, M.M., Offord, R.E. & Hartley, O. Nat. Rev. Immunol. 6, 371-382 (2006).
2. Geijtenbeek, T.B. et al. Cell 100, 587-597 (2000).
3. Turville, S.G. et al. Blood 103, 2170-2179 (2004).
4. Turville, S.G. et al. Nat. Immunol. 3, 975-983 (2002).
5. Veazey, R.S. et al. Nature 438, 99-102 (2005).
6. Patterson, B.K. et al. Am. J. Pathol. 161, 867-873 (2002).
7. Kawamura, T., Kurtz, S.E., Blauvelt, A. & Shimada, S. J. Dermatol. Sci. 40, 147-155 (2005).
8. Pope, M. et al. Cell 78, 389-398 (1994).
9. Reece, J.C. et al. J. Exp. Med. 187, 1623-1631 (1998).
10. Kawamura, T. et al. Proc. Natl. Acad. Sci. USA 100, 8401-8406 (2003).
11. Kawamura, T. et al. J. Exp. Med. 192, 1491-1500 (2000).
12. Collins, K.B., Patterson, B.K., Naus, G.J., Landers, D.V. & Gupta, P. Nat. Med. 6, 475-479 (2000).
13. Banchereau, J. & Steinman, R.M. Nature 392, 245-252 (1998).
14. McDonald, D. et al. Science 300, 1295-1297 (2003).
15. Valladeau, J. et al. Immunity 12, 71-81 (2000).
16. Hunger, R.E. et al. J. Clin. Invest. 113, 701-708 (2004).
17. Masterson, A.J. et al. Blood 100, 701-703 (2002).
18. Garcia, E. et al. Traffic 6, 488-501 (2005).
19. Richters, C.D. et al. Clin. Exp. Immunol. 98, 330-336 (1994).
20. Nguyen, D.G. & Hildreth, J.E. Eur. J. Immunol. 33, 483-493 (2003).
21. Kawamura, T., Qualbani, M., Thomas, E.K., Orenstein, J.M. & Blauvelt, A. Eur. J. Immunol. 31, 360-368 (2001).
22. Miller, C.J. & Hu, J. J. Infect. Dis. 179 (suppl. 3), 413-417 (1999).
23. Ward, E.M., Stambach, N.S., Drickamer, K. & Taylor, M.E. J. Biol. Chem. 281, 15450-15456 (2006).
24. Cohn, M.A. et al. J. Infect. Dis. 184, 410-417 (2001).
25. Picut, C.A., Lee, C.S., Dougherty, E.P., Andersen, K.L. & Lewis, R.M. J. Histochem. Cytochem. 35, 745-753 (1987).